Haw Par Corp. Ltd. (HAWPF)
10.80
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Haw Par Shareholders Equity (Quarterly)
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2019 | 2.347B |
| September 30, 2019 | 2.191B |
| June 30, 2019 | 2.251B |
| March 31, 2019 | 2.260B |
| December 31, 2018 | 2.148B |
| September 30, 2018 | 2.309B |
| June 30, 2018 | 2.322B |
| March 31, 2018 | 2.461B |
| December 31, 2017 | 2.303B |
| September 30, 2017 | 2.166B |
| June 30, 2017 | 2.061B |
| March 31, 2017 | 1.921B |
| December 31, 2016 | 1.714B |
| September 30, 2016 | 1.750B |
| June 30, 2016 | 1.738B |
| March 31, 2016 | 1.818B |
| December 31, 2015 | 1.787B |
| September 30, 2015 | 1.705B |
| June 30, 2015 | 2.104B |
| March 31, 2015 | 2.016B |
| December 31, 2014 | 2.119B |
| September 30, 2014 | 2.061B |
| June 30, 2014 | 2.097B |
| March 31, 2014 | 1.987B |
| December 31, 2013 | 1.936B |
| Date | Value |
|---|---|
| September 30, 2013 | 1.900B |
| June 30, 2013 | 1.846B |
| March 31, 2013 | 1.903B |
| December 31, 2012 | 1.845B |
| September 30, 2012 | 1.789B |
| June 30, 2012 | 1.624B |
| March 31, 2012 | 1.615B |
| December 31, 2011 | 1.373B |
| September 30, 2011 | 1.437B |
| June 30, 2011 | 1.698B |
| March 31, 2011 | 1.589B |
| December 31, 2010 | 1.516B |
| September 30, 2010 | 1.448B |
| June 30, 2010 | |
| March 31, 2010 | 1.342B |
| December 31, 2009 | 1.355B |
| September 30, 2009 | 1.204B |
| June 30, 2009 | 1.071B |
| March 31, 2009 | 740.48M |
| December 31, 2008 | 916.23M |
| September 30, 2008 | 1.144B |
| June 30, 2008 | 1.348B |
| March 31, 2008 | 1.347B |
| December 31, 2007 | 1.339B |
| September 30, 2007 | 1.390B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| AstraZeneca PLC | 47.33B |
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
| Avadel Pharmaceuticals Plc | 98.22M |